Democrats’ Success in Drug Pricing Legislation Hinges on Select Group of Individuals
Democrats are attempting to lower drug prices through legislation. Ten individuals could determine the initiative’s outcome. “The effort’s success depends [...]
Drug Pricing App GoodRx Announces Revenue of $177 Million in Second Quarter of 2021
GoodRx has announced a 43% revenue increase in its second quarter, leading to $177 million in revenue. Its subscribers hit [...]
Biogen Tempts Alzheimer’s Patients with Free Aduhelm; Will Ploy Lead to Medicare Coverage of $56,000 Yearly Drug?
In a recent podcast offered by the American Academy of Neurology, Dr. Brian Callaghan shares his thoughts on the cost-effectiveness of [...]
Congressional Budget Office’s Updated Model Predicts Impact of Pricing Legislation on Pharma Innovation
The Congressional Budget Office (CBO) released an updated model intended to predict how drug pricing bills, including Medicare negotiation, would [...]
HEOR Policy Experts Present Drug Pricing Reform Options, Discuss FDA’s Accelerated Approval Mechanism and Pricing Negotiation
Health economics and outcomes research (HEOR) experts at the USC-Brookings Schaeffer Initiative for Health Policy and the Washington University School [...]
New JMCP Article on International Reference Pricing Assesses Global Models
Drs. Leah Rand and Aaron Kesselheim recently published an article in the Journal of Managed Care and Specialty Pharmacy (JMCP) [...]
Indegene Announces Acquisition of Medical Marketing Economics Group in $10 Million Deal
Indegene, a technology-powered healthcare solutions company, announced the acquisition of Medical Marketing Economics (MME) in a $10 million deal. MME [...]
ICER’s RWE Study of Hereditary Angioedema Treatments Provides New Insight
The Institute for Clinical and Economic Review (ICER) recently published results from a real world evidence study (RWE) assessing the [...]
Economists and Policy Experts Discuss Six Strategies to Address High Drug Costs
Paul Ginsberg and Steven Lieberman of the USC-Brookings Schaeffer Initiative for Health Policy discuss six policies that could address the [...]
Can the FDA’s Humorous Social Media Posts Combat Scientific Misinformation?
The Food and Drug Administration (FDA) is incorporating humor into its social media messages aimed at reducing the spread of [...]
Merck and Amgen Boldly Test the Limits of Prescription Drug Price Increases
Pharmaceutical companies generally keep drug prices increases around 5% per year. This year, Merck and Amgen tested that unofficial limit. [...]
Unions Are Helping Big Pharma Fight Democrats’ Prescription Drug Bill
A host of powerful unions are helping the pharmaceutical industry battle a key plank of President Joe Biden’s agenda, a [...]
News, Trends, Challenges in Specialty Pharmacy: Rx Drug Manufacturers, Benefits Decision Makers Find Solutions in AscellaHealth Developments in Specialty Pharmacy Newsletter
News, Trends, Challenges in Specialty Pharmacy: Rx Drug Manufacturers, Benefits Decision Makers Find Solutions in AscellaHealth Developments in Specialty Pharmacy [...]
New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many
Gene therapy uses our genomic makeup to treat or prevent disease. ktsimape/iStock via Getty Images Zolgensma – which treats spinal [...]
How machine learning can help drive the next pharmaceutical research renaissance
How machine learning can help drive the next pharmaceutical research renaissance By Derek Baird President North America at Sensyne Health [...]
PhRMA President Discusses Patient Centricity in Value Assessments
President of Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Eileen Cannon shared her thoughts on adding a patient-centered component [...]
Infographic Features Insight on Payers Throughout Drug Development Process
An infographic offered by Cyan Health provides insight into payer perceptions throughout drug development. Understanding the points at which payers [...]
New Cytel Whitepaper on Clinical Trial Optimization Using Pareto Efficiency
Cytel’s new whitepaper on optimizing clinical trial design discusses how to best allocate resources. Thoughtfully planning a clinical trial requires [...]
Part Two of ISMPP’s InformED Podcast on Understanding the Evolving Medical Conference Landscape Now Available
The newest installment of the International Society for Medical Publication Professionals (ISMPP)’s InformED podcast series on medical communications is now [...]
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings
Medicines that are based on known molecules and are further developed to address healthcare needs and deliver relevant improvement for [...]
Pharmaceutical Drug Delivery Market – Expected Revenue Gains During Forecast Period
Pharmaceutical Drug Delivery Market - Expected Revenue Gains During Forecast Period [Marketsandmarkets-New-HealthcareDomain] - Monday, August 30, 2021. Submitted by [NathMayur] [...]
Drug industry banks on its Covid clout to halt Dems’ push on prices
Drug industry banks on its Covid clout to halt Dems’ push on prices Major pharmaceutical companies are citing their role [...]
UK market access and the opportunities for pharma
The UK market access environment faces a time of change – the result of the convergence of several major drivers [...]
CBO: Impact of price control legislation on new drug development
It stands to reason that policies that aim to reduce drug prices or squeeze life science companies profits are likely [...]
Korea readies ‘preferential drug pricing’ for innovative medicines
The Korean government will consider introducing a “preferential drug pricing system” to support innovative pharmaceutical companies. Although the system had [...]